Stocks Could Rise For Companies Investing In Immunotherapy Treatments Seeking Alpha What I like about Vical is the company is not a one product house; it has several therapies in various stages of development, including TransVax, a first-in-class DNA vaccine, which is in phase III trials for hematopoietic stem cell transplant ... |
